(1) Repaglinide tablets are not indicated for patients with diabetic ketoacidosis or Type 1 diabetes. It should not be used with gemfibrozil, NPH-insulin or in patients with a known hypersensitivity to the drug.SOURCE Mylan Inc.
BTIG managing director Tim Chiang joined CNBC's 'Power Lunch' Tuesday afternoon to explain the 'buy' rating he has on Mylan (MYL) shares.
Citigroup analysts say recent public scrutiny over Mylan's (MYL) EpiPen won't affect its earnings, but could 'weigh on the stock's multiple' in the near term.
Senators Grassley, Blumenthal and Klobuchar demand Mylan reduce the price of its dominant treatment for life-threatening allergies.
Iowa Senator Chuck Grassley has officially requested Myaln (MYL) explain its price increases for the EpiPen.